Joerg Kaufmann
14Patents
3h-index
27Co-inventors
60Inventor score
Filing activity: Dec 10, 1998 → Nov 4, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7700359B2 | Gene products differentially expressed in cancerous cells | Chemistry; Metallurgy | 27 | Expired |
| US6566063B1 | Methods for determining metastatic potential of breast cancer cells by detecting GSEF gene product expression | Chemistry; Metallurgy | 5 | Expired |
| US6589745B2 | CIF130 inhibits cell cycle progression | Chemistry; Metallurgy | 3 | Expired |
| US6303372A | cDNA molecule encoding human CIF130 | Chemistry; Metallurgy | 2 | Expired |
| US7081517B2 | Genes differentially expressed in breast cancer | Chemistry; Metallurgy | 1 | Expired |
| US6174679A | CIF150/hTAFII150 is necessary for cell cycle progression | Chemistry; Metallurgy | 1 | Expired |
| US7605246B2 | Genes differentially expressed in breast cancer | Chemistry; Metallurgy | 0 | Expired |
| US9133515B2 | Use of VEGFR1 as a biomarker | Physics | 0 | Active |
| US8221983B2 | Gene products differentially expressed in cancerous cells | Chemistry; Metallurgy | 0 | Active |
| US11796540B2 | Methods for modulating signal intensity in interaction assays | Physics | 0 | Active |
| US7867731B2 | HX2004-6 polypeptide expressed in cancerous cells | Physics | 0 | Active |
| US6423822B1 | Human CIF130 polypeptides | Chemistry; Metallurgy | 0 | Expired |
| US8236928B2 | Genes differentially expressed in breast cancer | Chemistry; Metallurgy | 0 | Active |
| US11532845B2 | Battery cell | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.